Penserra Capital Management LLC Iveric Bio, Inc. Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$13.83 - $18.78 $32,846 - $44,602
-2,375 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$7.07 - $17.5 $2,262 - $5,600
320 Added 15.57%
2,375 $38,000
Q2 2021

Aug 12, 2021
BUY
$5.69 - $7.17 $113 - $143
20 Added 0.98%
2,055 $12,000
Q1 2021

May 13, 2021
SELL
$5.08 - $6.89 $101 - $137
-20 Reduced 0.97%
2,035 $12,000
Q4 2020

Feb 12, 2021
BUY
$5.65 - $7.66 $11,610 - $15,741
2,055 New
2,055 $14,000

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email